Physician profile
Eric Ginsberg
NPI 1083108732
$2,349.70
in general payments reported to CMS, 2019-2025
9 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,144 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,349.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $666.88 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $341.07 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $312.16 | 2025 | Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $310.02 | 2024 | Endurant Iis |
| W. L. Gore & Associates, INC. | $224.24 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $190.79 | 2025 | General - Vascular Intervention |
| Silk Road Medical, INC. | $166.94 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Surmodics, INC. | $87.60 | 2025 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Terumo Medical Corporation | $50.00 | 2025 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ginsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.